Julie U Vu, PA
Physician Assistant · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · One Health Medical Foundation · 12 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Julie U Vu’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A63916 · Current
Licensed to practise in California · since 1997 · expires 2027-10-31 · University of California, San Diego School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$141,854
Pharmacies billed $141,854 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,467) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
1,230 generic and fewer than 11 brand-name prescriptions · $141,854 in drug cost · 90 antibiotic prescriptions to 71 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 19 | $26,594 | $1,400 |
| Trelegy Ellipta | 23 | $14,786 | $643 |
| Jardiance | 13 | $13,738 | $1,057 |
| Linzess | 16 | $13,300 | $831 |
| Farxiga | 12 | $11,629 | $969 |
See all 34 drugs
| Vemlidy | 19 | $26,594 | $1,400 |
| Trelegy Ellipta | 23 | $14,786 | $643 |
| Jardiance | 13 | $13,738 | $1,057 |
| Linzess | 16 | $13,300 | $831 |
| Farxiga | 12 | $11,629 | $969 |
| Albuterol Sulfate Hfa | 49 | $1,377 | $28 |
| Fluticasone Propionate | 79 | $1,092 | $14 |
| Celecoxib | 23 | $885 | $38 |
| Atorvastatin | 90 | $829 | $9 |
| Amlodipine Besylate | 85 | $556 | $7 |
| Losartan | 68 | $534 | $8 |
| Diclofenac | 30 | $525 | $18 |
| Rosuvastatin | 51 | $512 | $10 |
| Valsartan-Hydrochlorothiazide | 11 | $469 | $43 |
| Tamsulosin | 29 | $423 | $15 |
| Omega-3 Acid Ethyl Esters | 14 | $405 | $29 |
| Losartan-Hydrochlorothiazide | 37 | $401 | $11 |
| Gabapentin | 26 | $355 | $14 |
| Metformin | 54 | $343 | $6 |
| Meclizine | 22 | $316 | $14 |
| Metoprolol | 18 | $308 | $17 |
| Triamcinolone Acetonide | 33 | $279 | $8 |
| Montelukast | 36 | $263 | $7 |
| Omeprazole | 41 | $249 | $6 |
| Azelastine | 15 | $220 | $15 |
| Alendronate | 22 | $176 | $8 |
| Amoxicillin-Clavulanate Potass | 22 | $159 | $7 |
| Nabumetone | 21 | $134 | $6 |
| Glipizide Er | 11 | $122 | $11 |
| Famotidine | 11 | $121 | $11 |
| Lisinopril | 17 | $106 | $6 |
| Baclofen | 16 | $88 | $6 |
| Azithromycin | 32 | $84 | $3 |
| Finasteride | 11 | $70 | $6 |
Money from drug and device companies
$939 in 2025
| 2025 | 10 | 22 | None | $939 |
| 2024 | 9 | 17 | None | $415 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $196 | 5 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $183 | 2 payments
|
| Viatris Specialty | Yupelri | $152 | 2 payments
|
| Gilead Sciences | None | $150 | 1 payment
|
| Abbvie | Linzess | $111 | 5 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $51 | 2 payments
|
See all 22 published payments
| Abbvie | Meals · 2025-12-03 | Linzess | $26 |
| Sumitomo Pharma America | Meals · 2025-11-14 | Gemtesa | $18 |
| Novo Nordisk | Meals · 2025-10-11 | Wegovy | $15 |
| Novo Nordisk | Meals · 2025-09-24 | Wegovy | $10 |
| Novo Nordisk | Meals · 2025-09-24 | Wegovy | $19 |
| GlaxoSmithKline | Meals · 2025-09-11 | Trelegy Ellipta | $16 |
| Lilly USA | Meals · 2025-08-25 | Mounjaro | $22 |
| Abbvie | Meals · 2025-08-19 | Linzess | $28 |
| Novo Nordisk | Meals · 2025-08-14 | Wegovy | $28 |
| Madrigal Pharmaceuticals | Meals · 2025-08-07 | Rezdiffra | $61 |
| Abbvie | Meals · 2025-07-26 | Linzess | $21 |
| Abbvie | Meals · 2025-07-11 | Linzess | $21 |
| Sumitomo Pharma America | Meals · 2025-06-05 | Gemtesa | $14 |
| Madrigal Pharmaceuticals | Meals · 2025-05-21 | Rezdiffra | $122 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-02 | Kerendia | $25 |
| Novo Nordisk | Meals · 2025-04-23 | Ozempic | $125 |
| Gilead Sciences | Meals · 2025-04-16 | None | $150 |
| Abbvie | Meals · 2025-04-02 | Linzess | $15 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-21 | Kerendia | $26 |
| Viatris Specialty | Meals · 2025-03-06 | Yupelri | $125 |
| Amgen | Meals · 2025-02-11 | Repatha | $26 |
| Viatris Specialty | Meals · 2025-02-05 | Yupelri | $27 |
See earlier years (2024)
2024: $415
| AstraZeneca Pharmaceuticals LP | Farxiga | $64 | 3 payments
|
| Merck Sharp & Dohme | Gardasil | $61 | 2 payments
|
| Lilly USA | Mounjaro | $56 | 2 payments
|
| Novo Nordisk | Rybelsus | $54 | 3 payments
|
| Amgen | Otezla | $54 | 2 payments
|
| Pfizer | Nurtec Odt | $38 | 2 payments
|
| Insmed | Arikayce | $33 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $29 | 1 payment
|
| GlaxoSmithKline | Arexvy | $27 | 1 payment
|
Professional record
- NPI
- 1861171183
- Licence
- CA 63916California A63916: Current · expires 2027-10-31
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 36922 Montecito Dr, Fremont, CA, 94536
- NPI first listed
- 2023-07-13
- NPI last updated
- 2024-02-20
- NPI record certified
- 2024-02-20
This is when the NPI record was last certified, not a medical board exam.